WallStreetZenWallStreetZen

NASDAQ: THAR
Tharimmune Inc Stock Ownership - Who owns Tharimmune?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Tharimmune Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sanam ParikhDirector2025-06-201,000$1.45
$1.45kBuy
Sireesh AppajosyulaChief Executive Officer2025-06-2060,806$1.48
$89.99kBuy
Sireesh AppajosyulaChief Executive Officer2025-06-20690$1.42
$979.80Buy
Gravitas Capital LPExecutive Chairman2025-06-20337,838$1.48
$500.00kBuy
Sanam ParikhDirector2025-05-15770$1.30
$1.00kBuy
Randy MilbyCEO2024-12-194,600$2.12
$9.75kBuy
Sireesh AppajosyulaChief Operating Officer2024-11-135,000$2.02
$10.10kBuy
Randy MilbyCEO2024-10-08354$2.10
$743.40Buy
Randy MilbyCEO2024-10-08646$2.09
$1.35kBuy
Randy MilbyCEO2024-10-081,500$2.09
$3.13kBuy

1 of 2

THAR insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when THAR insiders and whales buy or sell their stock.

THAR Shareholders

What type of owners hold Tharimmune Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Highpoint Pharmaceuticals LLC20.97%972,222$5.94MInsider
Kufe LLC17.48%810,395$4.95MInsider
Gravitas Capital LP15.80%732,424$4.48MInsider
Vincent S. Lopriore15.80%732,424$4.48MInsider
Surender Kharbanda15.56%721,240$4.41MInsider
Varinder Kaur14.09%653,059$3.99MInsider
Sandeep Laumas13.72%636,008$3.89MInsider
Leonard L. Mazur2.67%123,733$756.01kInsider
Gary S. Stetz2.19%101,351$619.25kInsider
Sireesh Appajosyula1.40%64,889$396.47kInsider

1 of 3

THAR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
THAR1.80%98.20%Net BuyingNet Buying
NNVC2.48%97.52%
GDTC0.39%57.45%
ALLR1.33%13.58%Net Buying
CTXR5.46%61.19%
View Top Biotech Stocks

Tharimmune Stock Ownership FAQ

Who owns Tharimmune?

Tharimmune (NASDAQ: THAR) is owned by 2.20% institutional shareholders, 120.24% Tharimmune insiders, and 0.00% retail investors. Highpoint Pharmaceuticals LLC is the largest individual Tharimmune shareholder, owning 972,222.00 shares representing 20.97% of the company. Highpoint Pharmaceuticals LLC's Tharimmune shares are currently valued at $4.82M.

If you're new to stock investing, here's how to buy Tharimmune stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.